Robert B. Ford, received $24.2M in total compensation as Chairman of the Board and Chief Executive Officer of ABBOTT LABORATORIES in FY2025. The largest component was $8.8M in option awards. That’s up 6% from FY2024. Source: SEC DEF 14A.
Executive Compensation Summary for ABBOTT LABORATORIES
Robert B. Ford, Salary and Compensation - ABBOTT LABORATORIES CEO Pay 2025
In fiscal year 2025, Robert B. Ford,, Chairman of the Board and Chief Executive Officer of ABBOTT LABORATORIES (ABT), received total compensation of $24.2 million.
Robert B. Ford,'s compensation breakdown includes: base salary of $1.5 million, stock awards valued at $8.8 million, option awards of $8.8 million, non-equity incentive compensation of $2.0 million, and other compensation of $960K.
Compared to fiscal year 2024, Robert B. Ford,'s total compensation increased 6% from $22.8 million to $24.2 million.
ABBOTT LABORATORIES (ABT) Executive Pay 2025
ABBOTT LABORATORIES's top 6 named executive officers received combined total compensation of $61.5 million in fiscal year 2025.
The named executive officers disclosed in ABBOTT LABORATORIES's 2025 proxy statement are:Robert B. Ford, (Chairman of the Board and Chief Executive Officer) with total compensation of $24.2 million, Philip P. Boudreau (Executive Vice President, Finance and Chief Financial Officer) with total compensation of $9.1 million, Lisa D. Earnhardt (Executive Vice President and Group President, Medical Devices) with total compensation of $8.1 million, Hubert L. Allen, (Executive Vice President, General Counsel and Secretary) with total compensation of $7.0 million, Christopher J. Scoggins (Executive Vice President, Diabetes Care) with total compensation of $6.6 million, and Daniel G. Salvadori, (Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products) with total compensation of $6.5 million.